Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HPMPC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 90 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Snoeck, R; Bossens, M; Parent, D; Delaere, B; Degreef, H; Van Ranst, M; Noel, JC; Wulfsohn, MS; Rooney, JF; Jaffe, HS; De Clercq, E
      Phase II double-blind, placebo-controlled study of the safety and efficacyof cidofovir topical gel for the treatment of patients with human papillomavirus infection

      CLINICAL INFECTIOUS DISEASES
    2. Andrei, G; Snoeck, R; Schols, D; De Clercq, E
      Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positivecells

      ONCOLOGY RESEARCH
    3. Romanowski, EG; Yates, KA; Gordon, YJ
      Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model

      ANTIVIRAL RESEARCH
    4. Geerinck, K; Lukito, G; Snoeck, R; De Vos, R; De Clercq, E; Vanrenterghem, Y; Degreef, H; Maes, B
      A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

      JOURNAL OF MEDICAL VIROLOGY
    5. Koonsaeng, S; Verschraegen, C; Freedman, R; Bossens, M; Kudelka, A; Kavanagh, J; Sittisomwong, T; DeClercq, E; Snoeck, R
      Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir

      JOURNAL OF MEDICAL VIROLOGY
    6. Romanowski, EG; Gordon, YJ; Araullo-Cruz, T; Yates, KA; Kinchington, PR
      The antiviral resistance and replication of cidofovir-resistant adenovirusvariants in the New Zealand White rabbit ocular model

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    7. Romanowski, EG; Gordon, YJ
      Effects of diclofenac or ketorolac on the inhibitory activity of cidofovirin the Ad5/NZW rabbit model

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    8. Liekens, S; Verbeken, E; De Clercq, E; Neyts, J
      Potent inhibition of hemangiosarcoma development in mice by cidofovir

      INTERNATIONAL JOURNAL OF CANCER
    9. Hillenkamp, J; Reinhard, T; Ross, RS; Bohringer, D; Cartsburg, O; Roggendorf, M; De Clercq, E; Godehardt, E; Sundmacher, R
      Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine - A controlled clinical pilot study

      ARCHIVES OF OPHTHALMOLOGY
    10. Hoffman, VF; Skiest, DJ
      Therapeutic developments in cytomegalovirus retinitis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Kaufman, HE
      Treatment of viral diseases of the cornea and external eye

      PROGRESS IN RETINAL AND EYE RESEARCH
    12. Ho, ES; Lin, DC; Mendel, DB; Cihlar, T
      Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced bythe expression of human renal organic anion transporter 1

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    13. Snoeck, R
      Antiviral therapy of herpes simplex

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    14. Smee, DF; Bailey, KW; Wong, MH; Sidwell, RW
      Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

      ANTIVIRAL RESEARCH
    15. Romanowski, EG; Gordon, YJ
      Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    16. Jeffery, AL; Kim, JH; Wiemer, DF
      Synthesis of acyclic nucleoside and nucleotide analogues from amino acids:A convenient approach to a PMEA-PMPA hybrid

      TETRAHEDRON
    17. Martinez, A; Gil, C; Perez, C; Castro, A; Prieto, C; Otero, J; Andrei, G; Snoeck, R; Balzarini, J; De Clercq, E
      Nonnucleoside human cytomegalovirus inhibitors: Synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    18. Bray, M; Martinez, M; Smee, DF; Kefauver, D; Thompson, E; Huggins, JW
      Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

      JOURNAL OF INFECTIOUS DISEASES
    19. Alexander, P; Holy, A; Budesinsky, M; Masojidkova, M
      Synthesis of acyclic nucleotide analogues derived from N-3-substituted isoguanine

      COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS
    20. Tseng, AL; Mortimer, CB; Salit, IE
      Iritis associated with intravenous cidofovir

      ANNALS OF PHARMACOTHERAPY
    21. Bainbridge, JWB; Raina, J; Shah, SM; Ainsworth, J; Pinching, AJ
      Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS

      EYE
    22. Cochereau, I; Doan, S; Diraison, MC; Mousalatti, H; Guvenisik, N; Ren, L; Hoang-Xuan, T
      Uveitis in patients treated with intravenous cidofovir

      OCULAR IMMUNOLOGY AND INFLAMMATION
    23. De Clercq, E; Andrei, G; Balzarini, J; Hatse, S; Liekens, S; Naesens, L; Neyts, J; Snoeck, R
      Antitumor potential of acyclic nucleoside phosphonates

      NUCLEOSIDES & NUCLEOTIDES
    24. Oliyai, R; Shaw, JP; Sueoka-Lennen, CM; Cundy, KC; Arimilli, MN; Jones, RJ; Lee, WA
      Aryl ester prodrugs of cyclic HPMPC. I: PhysicochemicaI characterization and in vitro biological stability

      PHARMACEUTICAL RESEARCH
    25. Oliyai, R; Lee, WA; Visor, GC; Yuan, LC
      Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, relative to its parent compound, cidofovir

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    26. Cundy, KC
      Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

      CLINICAL PHARMACOKINETICS
    27. Cheng, LY; Hostetler, KY; Gardner, MF; Avila, CP; Bergeron-Lynn, G; Severson, GM; Freeman, WR
      Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA)

      CURRENT EYE RESEARCH
    28. Bedard, J; May, S; Barbeau, D; Yuen, L; Rando, RF; Bowlin, TL
      A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors

      ANTIVIRAL RESEARCH
    29. Banker, AS; Arevalo, JF; Azen, SP; Munguia, D; Ishimoto, B; Rahhal, FM; Xiang, M; Freeman, WR
      Fluorophotometry in patients with human immunodeficiency virus with and without cytomegalovirus retinitis

      OPHTHALMOLOGY
    30. Romanowski, EG; Bartels, SP; Gordon, YJ
      Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovirin the HSV-1 rabbit keratitis model

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    31. Walmsley, S; Tseng, A
      Comparative tolerability of therapies for cytomegalovirus retinitis

      DRUG SAFETY
    32. Martinez, A; Esteban, AI; Castro, A; Gil, C; Conde, S; Andrei, G; Snoeck, R; Balzarini, J; De Clercq, E
      Novel potential agents for human cytomegalovirus infection: Synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides

      JOURNAL OF MEDICINAL CHEMISTRY
    33. Noble, S; Goa, KL
      Adefovir dipivoxil

      DRUGS
    34. Brody, SR; Humphreys, MH; Gambertoglio, JG; Schoenfeld, P; Cundy, KC; Aweeka, FT
      Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    35. Ambati, J; Wynne, KB; Angerame, MC; Robinson, MR
      Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis

      BRITISH JOURNAL OF OPHTHALMOLOGY
    36. Kaufman, HE; Varnell, ED; Thompson, HW
      Cidofovir and experimental herpetic stromal disease

      ARCHIVES OF OPHTHALMOLOGY
    37. LACY SA; HITCHCOCK MJM; LEE WA; TELLIER P; CUNDY KC
      EFFECT OF ORAL PROBENECID COADMINISTRATION ON THE CHRONIC TOXICITY AND PHARMACOKINETICS OF INTRAVENOUS CIDOFOVIR IN CYNOMOLGUS MONKEYS

      TOXICOLOGICAL SCIENCES
    38. TASKINTUNA I; RAHHAL FM; CAPPARELLI EV; CUNDY KC; FREEMAN WR
      INTRAVITREAL AND PLASMA CIDOFOVIR CONCENTRATIONS AFTER INTRAVITREAL AND INTRAVENOUS ADMINISTRATION IN AIDS PATIENTS WITH CYTOMEGALOVIRUS RETINITIS

      Journal of ocular pharmacology and therapeutics
    39. KENDLE JB; FANHAVARD P
      CIDOFOVIR IN THE TREATMENT OF CYTOMEGALOVIRAL DISEASE

      The Annals of pharmacotherapy
    40. VANHEMEL J; ESMANS EL; JOOS PE; DEGROOT A; DOMMISSE RA; BALZARINI JM; DECLERCQ ED
      SYNTHESIS AND BIOLOGICAL EVALUATION OF PHOSPHONATE DERIVATIVES OF SOME ACYCLIC PYRIDINE-C-NUCLEOSIDES

      Nucleosides & nucleotides
    41. EISENBERG EJ; LYNCH GR; BIDGOOD AM; KRISHNAMURTY K; CUNDY KC
      ISOLATION AND IDENTIFICATION OF A METABOLITE OF CIDOFOVIR FROM RAT-KIDNEY

      Journal of pharmaceutical and biomedical analysis
    42. BIRKUS G; VOTRUBA I; HOLY A; OTOVA B
      PMEAPP AS A SUBSTRATE TOWARD REPLICATIVE DNA-POLYMERASE-ALPHA, DNA-POLYMERASE-DELTA, DNA-POLYMERASE-EPSILON AND DNA-POLYMERASE-EPSILON-ASTERISK

      Chemicke zvesti
    43. BANKER AS; BERGERONLYNN G; KEEFE KS; DECLERCQ E; TASKINTUNA I; FREEMAN WR
      EFFECTS OF TOPICAL AND SUBCONJUNCTIVAL CIDOFOVIR (HPMPC) IN AN ANIMAL-MODEL

      Current eye research
    44. Cochereau, I; Belayachi, N; Diraison, C; Matheron, S; Bouyer, I; Hoang-Xuan, T; Saimot, AG; Couland, JP
      Intravitreal foscarnet in CMV retinitis.

      JOURNAL FRANCAIS D OPHTALMOLOGIE
    45. DECLERCQ E
      ACYCLIC NUCLEOSIDE PHOSPHONATES - A NEW DIMENSION TO THE CHEMOTHERAPYOF DNA VIRUS AND RETROVIRUS INFECTIONS

      Journal of Medical Microbiology
    46. DECLERCQ E
      TOWARDS AN EFFECTIVE CHEMOTHERAPY OF VIRUS-INFECTIONS - THERAPEUTIC POTENTIAL OF CIDOFOVIR -1-[3-HYDROXY-2-(PHOSPHONOMETHOXY)PROPYL]CYTOSINE, HPMPC] FOR THE TREATMENT OF DNA VIRUS-INFECTIONS

      Collection of Czechoslovak Chemical Communications
    47. NEYTS J; SADLER R; DECLERCQ E; RAABTRAUB N; PAGANO JS
      THE ANTIVIRAL AGENT CIDOFOVIR -1-(3-HYDROXY-2-PHOSPHONYL-METHOXYPROPYL)CYTOSINE] HAS PRONOUNCED ACTIVITY AGAINST NASOPHARYNGEAL CARCINOMA GROWN IN NUDE-MICE

      Cancer research
    48. KAUFMAN HE; VARNELL ED; THOMPSON HW
      TRIFLURIDINE, CIDOFOVIR, AND PENCICLOVIR IN THE TREATMENT OF EXPERIMENTAL HERPETIC-KERATITIS

      Archives of ophthalmology
    49. HARDY WD
      MANAGEMENT STRATEGIES FOR PATIENTS WITH CYTOMEGALOVIRUS RETINITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    50. KUPPERMANN BD
      THERAPEUTIC OPTIONS FOR RESISTANT CYTOMEGALOVIRUS RETINITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    51. LALEZARI JP
      CIDOFOVIR - A NEW THERAPY FOR CYTOMEGALOVIRUS RETINITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    52. LALEZARI JP; KUPPERMANN BD
      CLINICAL-EXPERIENCE WITH CIDOFOVIR IN THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    53. SPECTOR SA
      CURRENT THERAPEUTIC CHALLENGES IN THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    54. NAESENS L; SNOECK R; ANDREI G; BALZARINI J; NEYTS J; DECLERCQ E
      HPMPC (CIDOFOVIR), PMEA (ADEFOVIR) AND RELATED ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS - A REVIEW OF THEIR PHARMACOLOGY AND CLINICAL POTENTIAL IN THE TREATMENT OF VIRAL-INFECTIONS

      Antiviral chemistry & chemotherapy
    55. NAESENS L; DECLERCQ E
      THERAPEUTIC POTENTIAL OF HPMPC (CIDOFOVIR), PMEA (ADEFOVIR) AND RELATED ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS AS BROAD-SPECTRUM ANTIVIRAL AGENTS

      Nucleosides & nucleotides
    56. DECLERCQ E
      ACYCLIC NUCLEOSIDE PHOSPHONATES IN THE CHEMOTHERAPY OF DNA VIRUS AND RETROVIRUS INFECTIONS

      Intervirology
    57. HOSOYA K; LEE VHL
      CIDOFOVIR TRANSPORT IN THE PIGMENTED RABBIT CONJUNCTIVA

      Current eye research
    58. KLOOVER JS; VANAGT WYR; STALS FS; BRUGGEMAN CA
      EFFECTIVE TREATMENT OF EXPERIMENTAL CYTOMEGALOVIRUS-INDUCED ENCEPHALO-MENINGITIS IN IMMUNOCOMPROMISED RATS WITH HPMPC

      Antiviral research
    59. CHAVEZDELAPAZ E; AREVALO JF; KIRSCH LS; MUNGUIA D; RAHHAL FM; DECLERCQ E; FREEMAN WR
      ANTERIOR NONGRANULOMATOUS UVEITIS AFTER INTRAVITREAL HPMPC (CIDOFOVIR) FOR THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS - ANALYSIS AND PREVENTION

      Ophthalmology
    60. ROMANOWSKI EG; ARAULLOCRUZ T; GORDON YJ
      TOPICAL CORTICOSTEROIDS REVERSE THE ANTIVIRAL EFFECT OF TOPICAL CIDOFOVIR IN THE AD5-INOCULATED NEW-ZEALAND RABBIT OCULAR MODEL

      Investigative ophthalmology & visual science
    61. NEYTS J; DECLERCQ E
      ANTIVIRAL DRUG SUSCEPTIBILITY OF HUMAN-HERPESVIRUS-8

      Antimicrobial agents and chemotherapy
    62. TASKINTUNA I; BANKER AS; RAO NA; WILEY CA; FLORESAGUILAR M; MUNGUIA D; BERGERONLYNN G; DECLERCQ E; KEEFE K; FREEMAN WR
      AN ANIMAL-MODEL FOR CIDOFOVIR (HPMPC) TOXICITY - INTRAOCULAR-PRESSUREAND HISTOPATHOLOGIC EFFECTS

      Experimental Eye Research
    63. HITCHCOCK MJM; JAFFE HS; MARTIN JC; STAGG RJ
      CIDOFOVIR, A NEW AGENT WITH POTENT ANTI-HERPESVIRUS ACTIVITY

      Antiviral chemistry & chemotherapy
    64. GORDON YJ; NAESENS L; MAUDGAL PC
      TREATMENT OF ADENOVIRAL CONJUNCTIVITIS WITH TOPICAL CIDOFOVIR

      Cornea
    65. CUNDY KC; LYNCH G; SHAW JP; HITCHCOCK MJM; LEE WA
      DISTRIBUTION AND METABOLISM OF INTRAVITREAL CIDOFOVIR AND CYCLIC HPMPC IN RABBITS

      Current eye research
    66. DEOLIVEIRA CBR; STEVENSON D; LABREE L; MCDONNELL PJ; TROUSDALE MD
      EVALUATION OF CIDOFOVIR (HPMPC, GS-504) AGAINST ADENOVIRUS TYPE-5 INFECTION IN-VITRO AND IN A NEW-ZEALAND RABBIT OCULAR MODEL

      Antiviral research
    67. GORDON YJ; ARAULLOCRUZ TP; JOHNSON YF; ROMANOWSKI EG; KINCHINGTON PR
      ISOLATION OF HUMAN ADENOVIRUS TYPE-5 VARIANTS RESISTANT TO THE ANTIVIRAL CIDOFOVIR

      Investigative ophthalmology & visual science
    68. CUNDY KC; LI ZH; HITCHCOCK MJM; LEE WA
      PHARMACOKINETICS OF CIDOFOVIR IN MONKEYS - EVIDENCE FOR A PROLONGED ELIMINATION PHASE REPRESENTING PHOSPHORYLATED DRUG

      Drug metabolism and disposition
    69. CIHLAR T; CHEN MS
      IDENTIFICATION OF ENZYMES CATALYZING 2-STEP PHOSPHORYLATION OF CIDOFOVIR AND THE EFFECT OF CYTOMEGALOVIRUS-INFECTION ON THEIR ACTIVITIES INHOST-CELLS

      Molecular pharmacology
    70. KUPPERMANN BD; ASSIL KK; VUONG C; BESEN G; WILEY CA; DECLERCQ E; BERGERONLYNN G; CONNOR JD; PURSLEY M; MUNGUIA D; FREEMAN WR
      LIPOSOME-ENCAPSULATED (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL) FORLONG-ACTING THERAPY OF VIRAL RETINITIS

      The Journal of infectious diseases
    71. KIM JW; ELHAIG W; CAPPARELLI EV; BESEN G; CONNOR JD; FREEMAN WR
      EFFECT OF PARTIAL RETINAL DESTRUCTION AND GLIOSIS ON THE INTRAVITREALPHARMACOKINETICS OF HPMPC

      Retina
    72. SMEE DF; BARNETT BB; SIDWELL RW; REIST EJ; HOLY A
      ANTIVIRAL ACTIVITIES OF NUCLEOSIDES AND NUCLEOTIDES AGAINST WILD-TYPEAND DRUG-RESISTANT STRAINS OF MURINE CYTOMEGALOVIRUS

      Antiviral research
    73. VANCUTSEM E; SNOECK R; VANRANST M; FITEN P; OPDENAKKER G; GEBOES K; JANSSENS J; RUTGEERTS P; VANTRAPPEN G; DECLERCQ E
      SUCCESSFUL TREATMENT OF A SQUAMOUS PAPILLOMA OF THE HYPOPHARYNX-ESOPHAGUS BY LOCAL INJECTIONS OF S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE

      Journal of medical virology
    74. MENDEL DB; BARKHIMER DB; CHEN MS
      BIOCHEMICAL BASIS FOR INCREASED SUSCEPTIBILITY TO CIDOFOVIR OF HERPES-SIMPLEX VIRUSES WITH ALTERED OR DEFICIENT THYMIDINE KINASE-ACTIVITY

      Antimicrobial agents and chemotherapy
    75. POLIS MA; SPOONER KM; BAIRD BF; MANISCHEWITZ JF; JAFFE HS; FISHER PE; FALLOON J; DAVEY RT; KOVACS JA; WALKER RE; WHITCUP SM; NUSSENBLATT RB; LANE HC; MASUR H
      ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA

      Antimicrobial agents and chemotherapy
    76. ADUMA P; CONNELLY MC; SRINIVAS RV; FRIDLAND A
      METABOLIC DIVERSITY AND ANTIVIRAL ACTIVITIES OF ACYCLIC NUCLEOSIDE PHOSPHONATES

      Molecular pharmacology
    77. ASPE E; GUY RH; LEE WA; KENNEDY JA; VISOR GC; ENNIS RD
      OPTIMIZATION OF IN-VITRO FLUX THROUGH HAIRLESS MOUSE SKIN OF CIDOFOVIR POTENT NUCLEOTIDE ANALOG

      Journal of pharmaceutical sciences
    78. ZIDEK Z; HOLY A; FRANKOVA D; OTOVA B
      SUPPRESSION OF RAT ADJUVANT ARTHRITIS BY SOME ACYCLIC NUCLEOTIDE ANALOGS

      European journal of pharmacology
    79. SMEE DF; SUGIYAMA ST; SIDWELL RW; BARNETT BB
      EFFECTS OF MONOCLONAL-ANTIBODY COMBINED WITH GANCICLOVIR OR -1[3-HYDROXY-(2-PHOSPHONYLMETHOXY)-PROPYL]CYTOSINE AGAINST MURINE CYTOMEGALOVIRUS INFECTIONS IN CELL-CULTURE AND IN SEVERE COMBINED IMMUNODEFICIENT MICE

      Chemotherapy
    80. BESEN G; FLORESAGUILAR M; ASSIL KK; KUPPERMAN BD; GANGAN P; PURSLEY M; MUNGUIA D; VUONG C; DECLERCQ E; BERGERONLYNN G; AZEN SP; FREEMAN WR
      LONG-TERM THERAPY FOR HERPES RETINITIS IN AN ANIMAL-MODEL WITH HIGH-CONCENTRATED LIPOSOME-ENCAPSULATED HPMPC

      Archives of ophthalmology
    81. SMEE DF; LEONHARDT JA; SUGIYAMA ST; HOLY A
      INHIBITORS OF BOVINE HERPES MAMMILLITIS VIRUS-INFECTIONS IN CULTURED-CELLS AND IN VAGINALLY INFECTED GUINEA-PIGS

      Antiviral chemistry & chemotherapy
    82. GORDON YJ; ROMANOWSKI EG; ARAULLOCRUZ T
      HPMPC, A BROAD-SPECTRUM TOPICAL ANTIVIRAL AGENT, INHIBITS HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION AND PROMOTES HEALING OF DENDRITIC KERATITIS IN THE NEW-ZEALAND RABBIT OCULAR MODEL

      Cornea
    83. GORDON YJ; ROMANOWSKI EG; ARAULLOCRUZ T
      HPMPC, A BROAD-SPECTRUM TOPICAL ANTIVIRAL AGENT, INHIBITS HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION AND PROMOTES HEALING OF DENDRITIC KERATITIS IN THE NEW-ZEALAND RABBIT OCULAR MODEL

      Cornea
    84. GORDON YJ; ROMANOWSKI EG; ARAULLOCRUZ T
      TOPICAL HPMPC INHIBITS ADENOVIRUS TYPE-5 IN THE NEW-ZEALAND RABBIT OCULAR REPLICATION MODEL

      Investigative ophthalmology & visual science
    85. BISCHOFBERGER N; HITCHCOCK MJM; CHEN MS; BARKHIMER DB; CUNDY KC; KENT KM; LACY SA; LEE WA; LI ZH; MENDEL DB; SMEE DF; SMITH JL
      -OXO-1,4,2-DIOXAPHOSPHORINAN-5-YL)METHYL]CYTOSINE, AN INTRACELLULAR PRODRUG FOR S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE WITH IMPROVED THERAPEUTIC INDEX IN-VIVO

      Antimicrobial agents and chemotherapy
    86. MOORE MR; HAMZEH FM; LEE FEH; LIETMAN PS
      ACTIVITY OF (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL) CYTOSINE AGAINST HUMAN CYTOMEGALOVIRUS WHEN ADMINISTERED AS SINGLE-BOLUS DOSE AND CONTINUOUS-INFUSION IN IN-VITRO CELL-CULTURE PERFUSION SYSTEM

      Antimicrobial agents and chemotherapy
    87. DECLERCQ E
      THERAPEUTIC POTENTIAL OF HPMPC AS AN ANTIVIRAL DRUG

      Reviews in medical virology
    88. BRAVO FJ; STANBERRY LR; KIER AB; VOGT PE; KERN ER
      EVALUATION OF HPMPC THERAPY FOR PRIMARY AND RECURRENT GENITAL HERPES IN MICE AND GUINEA-PIGS

      Antiviral research
    89. NEYTS J; DECLERCQ E
      EFFICACY OF S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE FOR THE TREATMENT OF LETHAL VACCINIA VIRUS-INFECTIONS IN SEVERE COMBINED IMMUNE-DEFICIENCY (SCID) MICE

      Journal of medical virology
    90. BILA V; OTOVA B; JELINEK R; SLADKA M; MEJSNAROVA B; HOLY A; KREN V
      ANTIMITOTIC AND TERATOGENIC EFFECTS OF ACYCLIC NUCLEOTIDE ANALOGS 1-(S)-(3-HYDROXY-2-PHOSPHONOMETHOXYETHYL)CYTOSINE (HPMPC) AND 9-(2-PHOSPHONOMETHOXYETHYL)ADENINE (PMEA)

      Folia biologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 00:24:11